VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 676 filers reported holding VANECK VECTORS ETF TR in Q3 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $303,141 | -10.6% | 11,265 | 0.0% | 0.10% | -12.1% |
| Q2 2023 | $339,189 | -6.9% | 11,265 | 0.0% | 0.12% | -7.9% |
| Q1 2023 | $364,423 | +12.9% | 11,265 | 0.0% | 0.13% | +5.0% |
| Q4 2022 | $322,855 | +18.7% | 11,265 | 0.0% | 0.12% | +5.3% |
| Q3 2022 | $272,000 | -11.7% | 11,265 | 0.0% | 0.11% | -3.4% |
| Q2 2022 | $308,000 | -28.7% | 11,265 | 0.0% | 0.12% | -11.3% |
| Q1 2022 | $432,000 | +25.6% | 11,265 | 0.0% | 0.13% | +26.7% |
| Q4 2021 | $344,000 | +2.7% | 11,265 | 0.0% | 0.10% | -3.7% |
| Q3 2021 | $335,000 | -12.5% | 11,265 | 0.0% | 0.11% | -14.2% |
| Q2 2021 | $383,000 | +4.6% | 11,265 | 0.0% | 0.13% | -11.8% |
| Q1 2021 | $366,000 | -9.9% | 11,265 | 0.0% | 0.14% | -10.6% |
| Q4 2020 | $406,000 | -11.5% | 11,265 | 0.0% | 0.16% | -26.1% |
| Q3 2020 | $459,000 | +6.0% | 11,265 | 0.0% | 0.22% | +9.0% |
| Q2 2020 | $433,000 | +28.5% | 11,265 | 0.0% | 0.20% | +7.0% |
| Q1 2020 | $337,000 | +2.1% | 11,265 | 0.0% | 0.19% | +19.1% |
| Q4 2019 | $330,000 | +9.6% | 11,265 | 0.0% | 0.16% | +5.4% |
| Q3 2019 | $301,000 | +4.9% | 11,265 | 0.0% | 0.15% | -2.6% |
| Q2 2019 | $287,000 | +13.9% | 11,265 | 0.0% | 0.15% | +10.1% |
| Q1 2019 | $252,000 | +6.3% | 11,265 | 0.0% | 0.14% | -7.3% |
| Q4 2018 | $237,000 | +13.9% | 11,265 | 0.0% | 0.15% | +44.2% |
| Q3 2018 | $208,000 | -17.1% | 11,265 | 0.0% | 0.10% | -28.3% |
| Q2 2018 | $251,000 | +1.6% | 11,265 | 0.0% | 0.14% | +1.4% |
| Q1 2018 | $247,000 | -5.4% | 11,265 | 0.0% | 0.14% | -4.0% |
| Q4 2017 | $261,000 | +2272.7% | 11,265 | +2153.0% | 0.15% | +2028.6% |
| Q3 2017 | $11,000 | 0.0% | 500 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $11,000 | -99.9% | 500 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $11,405,000 | +9.0% | 500 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $10,460,000 | -20.8% | 500 | 0.0% | 0.01% | -22.2% |
| Q3 2016 | $13,215,000 | – | 500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |